Coronavirus Update: Moderna Progesses To Phase II, Russia Approves Homegrown Antiviral

CanSino Has Produced Fuller Data

Moderna maintains its lightning pace, but questions about its Phase III trial design remain.

US_Protest
Washington, DC, 30 May: Protests over the death of George Floyd have exploded across the US. The mass gatherings are worrying public health experts, including ex-FDA commissioner Scott Gottlieb, who says they could fuel a rise in COVID-19 infections.

The first participants have been dosed in the Moderna Inc.’s Phase II study of its novel coronavirus vaccine mRNA-1273.

The US biotech company is the focus of huge attention as a front-runner in the race to develop a vaccine...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip